{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:20:14Z","timestamp":1790882414983,"version":"4.1.0"},"reference-count":54,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.29411","type":"journal-article","created":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T18:31:08Z","timestamp":1607970668000},"page":"e2029411","source":"Crossref","is-referenced-by-count":50,"title":["Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients"],"prefix":"10.1001","volume":"3","author":[{"given":"Laura B.","family":"Ramsey","sequence":"first","affiliation":[{"name":"Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, Ohio"},{"name":"Divisions of Research in Patient Services and Clinical Pharmacology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry H.","family":"Ong","sequence":"additional","affiliation":[{"name":"Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Schildcrout","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh Anne","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Kevin","family":"Hicks","sequence":"additional","affiliation":[{"name":"Department of Individualized Cancer Management, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihal","family":"El Rouby","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy and Translational Research, University of Florida, Gainesville"},{"name":"James Winkle College of Pharmacy, University of Cincinnati, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa H.","family":"Cavallari","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy and Translational Research, University of Florida, Gainesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sony","family":"Tuteja","sequence":"additional","affiliation":[{"name":"Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina L.","family":"Aquilante","sequence":"additional","affiliation":[{"name":"Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber L.","family":"Beitelshees","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Maryland, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Lemkin","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, University of Maryland, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn V.","family":"Blake","sequence":"additional","affiliation":[{"name":"Center for Pharmacogenomics and Translational Research, Nemours Children\u2019s Health System, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Williams","sequence":"additional","affiliation":[{"name":"Nemours Research Institute, Nemours Children\u2019s Health System, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Cimino","sequence":"additional","affiliation":[{"name":"Informatics Institute, University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittney H.","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nita A.","family":"Limdi","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip E.","family":"Empey","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Horvat","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Kao","sequence":"additional","affiliation":[{"name":"Department of Medicine, School of Medicine, University of Colorado, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria P.","family":"Lipori","sequence":"additional","affiliation":[{"name":"University of Florida Health and University of Florida Health Sciences Center, Gainesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc B.","family":"Rosenman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Indiana University School of Medicine, Indianapolis"},{"name":"Department of Pediatrics, Ann & Robert H. Lurie Children\u2019s Hospital of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd C.","family":"Skaar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Indiana University School of Medicine, Indianapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgenia","family":"Teal","sequence":"additional","affiliation":[{"name":"Regenstrief Institute, Indianapolis, Indiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almut G.","family":"Winterstein","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Outcomes and Policy and Center for Drug Evaluation and Safety, University of Florida, Gainesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniwaa","family":"Owusu Obeng","sequence":"additional","affiliation":[{"name":"The Charles Bronfman Institute for Personalized Medicine, Departments of Medicine and Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Salyakina","sequence":"additional","affiliation":[{"name":"Personalized Medicine Initiative, Nicklaus Children\u2019s Health System, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apeksha","family":"Gupta","sequence":"additional","affiliation":[{"name":"Personalized Medicine Initiative, Nicklaus Children\u2019s Health System, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Gruber","sequence":"additional","affiliation":[{"name":"Personalized Medicine Initiative, Nicklaus Children\u2019s Health System, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"McCafferty-Fernandez","sequence":"additional","affiliation":[{"name":"Personalized Medicine Initiative, Nicklaus Children\u2019s Health System, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Bishop","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Pharmacology, University of Minnesota College of Pharmacy, Minneapolis"},{"name":"Department of Psychiatry, University of Minnesota Medical School, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zach","family":"Rivers","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Care and Health Systems, University of Minnesota College of Pharmacy, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Benner","sequence":"additional","affiliation":[{"name":"Clinical and Translational Science Institute, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bani","family":"Tamraz","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janel","family":"Long-Boyle","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh F.","family":"Peterson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara L.","family":"Van Driest","sequence":"additional","affiliation":[{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"},{"name":"Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"IGNITE Pharmacogenetics Working Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,12,14]]},"reference":[{"issue":"7573","key":"zoi200934r1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nature15817","article-title":"Pharmacogenomics in the clinic.","volume":"526","author":"Relling","year":"2015","journal-title":"Nature"},{"issue":"3","key":"zoi200934r4","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/clpt.2010.279","article-title":"CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network.","volume":"89","author":"Relling","year":"2011","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"zoi200934r5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/cpt.v107.1","article-title":"The Clinical Pharmacogenetics Implementation Consortium: 10 years later.","volume":"107","author":"Relling","year":"2020","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"zoi200934r6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2174\/1389200215666140130124910","article-title":"Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process.","volume":"15","author":"Caudle","year":"2014","journal-title":"Curr Drug Metab"},{"issue":"April","key":"zoi200934r8","first-page":"78","article-title":"Pharmacogenomics and adverse drug reactions in children.","volume":"5","author":"Rieder","year":"2014","journal-title":"Front Genet"},{"issue":"1","key":"zoi200934r9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1146\/annurev-pharmtox-010919-023459","article-title":"Gene-based dose optimization in children.","volume":"60","author":"Ramsey","year":"2020","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"zoi200934r10","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/cts.v12.2","article-title":"Considerations for implementing precision therapeutics for children.","volume":"12","author":"McLaughlin","year":"2019","journal-title":"Clin Transl Sci"},{"issue":"1","key":"zoi200934r11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/cpt.v102.1","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP2C19 and voriconazole therapy.","volume":"102","author":"Moriyama","year":"2017","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"zoi200934r12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/cpt.2019.106.issue-1","article-title":"Clinical Pharmacogenetics Implementation Consortium guideline for cytochrome P450 (CYP)2D6 genotype and atomoxetine therapy.","volume":"106","author":"Brown","year":"2019","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"zoi200934r13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/cpt.668","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for pharmacogenetics-guided warfarin dosing: 2017 update.","volume":"102","author":"Johnson","year":"2017","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"zoi200934r14","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/jcph.1080","article-title":"Impact of SLCO1B1 genotype on pediatric simvastatin acid pharmacokinetics.","volume":"58","author":"Wagner","year":"2018","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"zoi200934r15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12920-015-0162-5","article-title":"The IGNITE network: a model for genomic medicine implementation and research.","volume":"9","author":"Weitzel","year":"2016","journal-title":"BMC Med Genomics"},{"issue":"10","key":"zoi200934r16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040296","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"4","author":"von Elm","year":"2007","journal-title":"PLoS Med"},{"issue":"3","key":"zoi200934r17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/cts.2017.10.issue-3","article-title":"The IGNITE Pharmacogenetics Working Group: an opportunity for building evidence with pharmacogenetic implementation in a real-world setting.","volume":"10","author":"Cavallari","year":"2017","journal-title":"Clin Transl Sci"},{"issue":"1","key":"zoi200934r18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/cts.v13.1","article-title":"Standardizing CYP2D6 genotype to phenotype translation: consensus recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group.","volume":"13","author":"Caudle","year":"2020","journal-title":"Clin Transl Sci"},{"key":"zoi200934r19","author":"Samwald","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"zoi200934r20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.5345","article-title":"Projected prevalence of actionable pharmacogenetic variants and level A drugs prescribed among US Veterans Health Administration pharmacy users.","volume":"2","author":"Chanfreau-Coffinier","year":"2019","journal-title":"JAMA Netw Open"},{"key":"zoi200934r21","doi-asserted-by":"crossref","DOI":"10.1097\/FPC.0000000000000418","article-title":"Identification of high-impact gene-drug pairs for pharmacogenetic testing in Alberta, Canada.","author":"Fan","year":"2020","journal-title":"Pharmacogenet Genomics"},{"issue":"10","key":"zoi200934r22","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1038\/s41436-019-0484-3","article-title":"Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing.","volume":"21","author":"Cavallari","year":"2019","journal-title":"Genet Med"},{"issue":"1","key":"zoi200934r23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/cpt.2019.105.issue-1","article-title":"Implementation of pharmacogenetics at Cincinnati Children\u2019s Hospital Medical Center: lessons learned over 14 years of personalizing medicine.","volume":"105","author":"Ramsey","year":"2019","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"zoi200934r24","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/cts.v12.2","article-title":"Novel implementation of genotype-guided proton pump inhibitor medication therapy in children: a pilot, randomized, multisite pragmatic trial.","volume":"12","author":"Cicali","year":"2019","journal-title":"Clin Transl Sci"},{"issue":"1","key":"zoi200934r25","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3479","article-title":"Pharmacogenetics for safe codeine use in sickle cell disease.","volume":"138","author":"Gammal","year":"2016","journal-title":"Pediatrics"},{"issue":"3","key":"zoi200934r26","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.bbmt.2015.11.011","article-title":"Genotype-directed dosing leads to optimized voriconazole levels in pediatric patients receiving hematopoietic stem cell transplantation.","volume":"22","author":"Teusink","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"zoi200934r27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/cpt.v102.2","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron.","volume":"102","author":"Bell","year":"2017","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"zoi200934r28","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/clpt.2013.254","article-title":"Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update.","volume":"95","author":"Crews","year":"2014","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"zoi200934r29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/clpt.2011.287","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype.","volume":"91","author":"Crews","year":"2012","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"zoi200934r30","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/clpt.2013.2","article-title":"Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.","volume":"93","author":"Hicks","year":"2013","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"zoi200934r31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/cpt.v102.1","article-title":"Clinical Pharmacogenetics Implementation Consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.","volume":"102","author":"Hicks","year":"2017","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"zoi200934r32","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/cpt.v103.5","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and tamoxifen therapy.","volume":"103","author":"Goetz","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"zoi200934r33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/cpt.v98.2","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors.","volume":"98","author":"Hicks","year":"2015","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"zoi200934r34","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/clpt.2013.105","article-title":"Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update.","volume":"94","author":"Scott","year":"2013","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"zoi200934r35","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/clpt.2011.132","article-title":"Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy.","volume":"90","author":"Scott","year":"2011","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"zoi200934r37","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev-biodatasci-020320-093614","article-title":"Biomedical data science and informatics challenges to implementing pharmacogenomics with electronic health records.","volume":"3","author":"Hoffman","year":"2020","journal-title":"Annu Rev Biomed Data Sci"},{"issue":"6","key":"zoi200934r40","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1002\/cpt.2019.105.issue-6","article-title":"The case for pharmacogenetics-guided prescribing of codeine in children.","volume":"105","author":"Gammal","year":"2019","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"zoi200934r41","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0205","article-title":"FDA approval of extended-release oxycodone for children with severe pain.","volume":"137","author":"Yang","year":"2016","journal-title":"Pediatrics"},{"issue":"3","key":"zoi200934r42","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/0885-3924(96)00050-4","article-title":"Attenuation of morphine-induced delirium in palliative care by substitution with infusion of oxycodone.","volume":"12","author":"Maddocks","year":"1996","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"zoi200934r43","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1185\/030079908X253708","article-title":"Oxycodone: a review of its use in the management of pain.","volume":"24","author":"Riley","year":"2008","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"zoi200934r44","article-title":"Oxycodone for cancer-related pain.","volume":"8","author":"Schmidt-Hansen","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"zoi200934r45","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/bcp.1992.33.issue-6","article-title":"The pharmacokinetics and metabolism of oxycodone after intramuscular and oral administration to healthy subjects.","volume":"33","author":"P\u00f6yhi\u00e4","year":"1992","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"zoi200934r46","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1124\/dmd.32.4.447","article-title":"Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes.","volume":"32","author":"Lalovic","year":"2004","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"zoi200934r47","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/clpt.1993.43","article-title":"Inhibition by fluoxetine of cytochrome P450 2D6 activity.","volume":"53","author":"Otton","year":"1993","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"zoi200934r48","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/sj.npp.1301479","article-title":"Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers.","volume":"33","author":"Comer","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"zoi200934r49","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMsa1406143","article-title":"Trends in opioid analgesic abuse and mortality in the United States.","volume":"372","author":"Dart","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi200934r50","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/cpt.v108.2","article-title":"Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and nonsteroidal anti-inflammatory drugs.","volume":"108","author":"Theken","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"zoi200934r51","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2C19 and proton pump inhibitor dosing.","author":"Lima","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"zoi200934r52","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1002\/cpt.2019.105.issue-5","article-title":"Standardized biogeographic grouping system for annotating populations in pharmacogenetic research.","volume":"105","author":"Huddart","year":"2019","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"zoi200934r53","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/(ISSN)1099-0461","article-title":"Ontogeny of human hepatic cytochromes P450.","volume":"21","author":"Hines","year":"2007","journal-title":"J Biochem Mol Toxicol"},{"issue":"1-2","key":"zoi200934r54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ijpharm.2012.05.079","article-title":"Developmental expression of drug metabolizing enzymes: impact on disposition in neonates and young children.","volume":"452","author":"Hines","year":"2013","journal-title":"Int J Pharm"},{"key":"zoi200934r2","unstructured":"US Food and Drug Administration. Table of pharmacogenomic biomarkers in drug labeling. Updated August 18, 2020. Accessed March 16, 2020. https:\/\/www.fda.gov\/drugs\/science-and-research-drugs\/table-pharmacogenomic-biomarkers-drug-labeling"},{"key":"zoi200934r3","unstructured":"US Food and Drug Administration. Table of pharmacogenetic associations. Published February 25, 2020. Accessed March 31, 2020. https:\/\/www.fda.gov\/medical-devices\/precision-medicine\/table-pharmacogenetic-associations"},{"key":"zoi200934r7","unstructured":"CPIC: Clinical Pharmacogenetics Implementation Corsortium. Modified September 30, 2020. Accessed March 31, 2020. https:\/\/cpicpgx.org\/"},{"key":"zoi200934r36","unstructured":"National Human Genome Research Institute. Implementing Genomics in Practice (IGNITE) II: Pragmatic Clinical Trials Network (PTN). Updated September 29, 2020. Accessed April 1, 2020. https:\/\/www.genome.gov\/Funded-Programs-Projects\/Implementing-Genomics-in-Practice-IGNITE-2-Pragmatic-Clinical-Trials-Network"},{"key":"zoi200934r38","unstructured":"US Food and Drug Administration. Safety review update of codeine use in children; new boxed warning and contraindication on use after tonsillectomy and\/or adenoidectomy. Published August 15, 2012. Accessed March 31, 2020. https:\/\/www.fda.gov\/media\/85072\/download"},{"key":"zoi200934r39","unstructured":"US Food and Drug Administration. FDA restricts use of prescription codeine pain and cough medicines and tramadol pain medicines in children; recommends against use in breastfeeding women. Updated September 21, 2015. Accessed March 31, 2020. https:\/\/www.fda.gov\/media\/104268\/download"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2774099\/ramsey_2020_oi_200934_1607354065.71421.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T18:31:26Z","timestamp":1607970686000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2774099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,14]]},"references-count":54,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.29411","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,14]]}}}